Tarvacin "Anti-PS" antiviral immunotherapy

[acer2000]

I found this information when surfing HIV forums lookin for info on new anti-retroviral therapies (with a focus on eradication):

This compound is called "Bavituximab" or "Tarvacin" - at least I think they are the same. Made by a company called Peregrine Pharmaceuticals. About halfway through this article on the NIH site it lists most of the pathogens this is effective against.

http://www3.niaid.nih.gov/Biodefense/PDF/tarvacin.pdf

Anti-Phospholipid Therapy / Bavituximab Anti-Viral

Duke University's Human Vaccine Institute and the Center for HIV/AIDS Vaccine Immunology (CHAVI) is currently investigating PS as a potential target for preventing and treating HIV infection.

 

[acer2000]

Similar sounding therapy that is being testing in HIV and prostate cancer:

New Synthetic Molecules Trigger Immune Response To HIV And Prostate Cancer

Yale chemist receives NIH Young Investigator Award for antibody targeting

 

[minimus]

Although it looks promising, it is a bad sign (to me at least) that the stock market value of Peregrine has declined 91% since 1996.

 

[August59]

Not sure if that would be a good sign that they are ripe for a buy out or should that have taken place before they fell that far?